SAN FRANCISCO, CA—A new analysis of the EXCEL trial shows that PCI continues to be noninferior to CABG through 5 years for patients with left main CAD, investigators reported here today. As reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results